Publications by authors named "Xiaorui Fu"

Claim this Profile
E
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.
Eirini Papadopoulou, Elena Fountzilas, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi, Georgios Tsaousis, Xiaorui Fu

Transl Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical Features, Prognostic Analysis and Predictive Model Construction of Central Nervous System Invasion in Peripheral T-Cell Lymphoma].
Ya-Ting Ma, Yan-Fang Chen, Zhi-Yuan Zhou, Lei Zhang, Xin Li, Xiao-Rui Fu

Zhongguo Shi Yan Xue Ye Xue Za Zhi· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and application of a whole transcriptome sequencing assay for the detection of gene fusions in clinical cancer specimens.
Songchen Zhao, Xinhua Du, Yan Zhang, Jing Bai, Lu Meng, Xiaorui Fu

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyrate-producing suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway.
Zhuangzhuang Shi, Min Li, Chen Zhang, Hongwen Li, Yue Zhang, Xiaorui Fu

Gut· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Linan Zhu, Xudong Zhang, Xiaorui Fu, Zhaoming Li, Zhenchang Sun

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Stepwise Interventional Strategy for the Removal of Adherent Totally Implanted Central Venous Access Port Catheters.
Jia-Yin Ding, Lei Li, Xiao-Rui Fu, Luo Xu, Peng-Xu Ding

Ann Vasc Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL.
Jinghua Mao, Jurui Ge, Shiqi Ding, Zhenchang Sun, Feifei Nan, Xiaorui Fu

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Landscape of Colorectal Mucinous Adenocarcinoma has Similarity with Intestinal Goblet Cell Differentiation.
Jianbo Liu, Siyuan Qiu, Xiaorui Fu, Bin Zhou, Ruijuan Zu

Curr Genomics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano-Selenium and Glutathione Enhance Cucumber Resistance to by Promoting Jasmonic Acid-Mediated Cucurbitacin Biosynthesis.
Yujiao Jia, Lanqi Chen, Lu Kang, Xiaorui Fu, Shuyang Zheng

ACS Nano· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Stability RuNi/C Electrocatalyst for Efficient Hydrogen Oxidation Reaction in Alkaline Condition.
Xiaorui Fu, Zanyu Chen, Shiyu Zhang, Jiajun Wang, Jia Ding

Small· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma.
Xin Wen, Hui Yu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu

Int Immunopharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium metabolism heterogeneity in pan-cancer: insights from bulk and single-cell RNA sequencing.
Xiaorui Fu, Yiqi Deng, Heng Xu, Yang Shu, Hai-Ning Chen

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma.
Zhuangzhuang Shi, Guoru Hu, Min W Li, Lei Zhang, Xin Li, Xiaorui Fu

Gut· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of Histologic Transformation and Prognosis for Follicular Lymphoma].
Tian-Jiao Zhao, Duo Xu, Xiao-Fei Chai, Yan-Fang Chen, Da-Ming Wang, Xiao-Rui Fu

Zhongguo Shi Yan Xue Ye Xue Za Zhi· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.
Xiaoshuang Kong, Xudong Zhang, Mengjie Ding, Xiaoyan Feng, Meng Dong, Xiaorui Fu

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.
Meng Lin, Xiaolong Wu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.
Zhenchang Sun, Wenjuan Wan, Xudong Zhang, Lei Zhang, Xin Li, Xiaorui Fu

J Cancer Res Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to overcome CAR-T cell resistance in clinical work: A single-institute experience.
Feifei Nan, Xiaorui Fu, Xinfeng Chen, Ling Li, Xin Li

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma.
Mingzhi Zhang, Dan Chen, Xiaorui Fu, Huimin Meng, Feifei Nan

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDGP followed by radiotherapy vs VIPD followed by radiotherapy in newly diagnosed early NK/T-cell lymphoma.
Lei Zhang, Chenxing Shangguan, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu

Leuk Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.
Xinhua Wang, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu

JAMA Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study.
Jing-Jing Wu, Wen-Hua Wang, Meng Dong, Shan-Shan Ma, Xu-Dong Zhang, Xiao-Rui Fu

Invest New Drugs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes.
Yaqin Xia, Jurui Ge, Zhenchang Sun, Feifei Nan, Wenjuan Wan, Xiaorui Fu

Leuk Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a predictive nomogram for preoperative deep vein thrombosis (DVT) in isolated calcaneal fracture.
Xinqun Cheng, Xiang Lei, Haifeng Wu, Hong Luo, Xiaorui Fu

Sci Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study.
Liangliang Ren, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu

Indian J Hematol Blood Transfus· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis